MedTrace Logo

Effect of Family Involvement Intervention on Anxiety, Independence, and Psychological Resilience in CABG Surgery Patients

NCT07243925 · Status: ACTIVE_NOT_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 54

Last updated 2025-11-24

No results posted yet for this study

Summary

This randomized controlled trial was conducted to examine the effect of a family-based intervention prior to coronary artery bypass grafting (CABG) surgery on patients' psychosocial and functional outcomes. In the intervention group, family members who would participate in the care process received structured training, and their active participation in the pre- and post-operative care process was ensured. The control group received standard care.

The study found that the family-based intervention reduced patients' preoperative anxiety levels, supported their independence, and strengthened their psychological resilience. The findings suggest that encouraging family involvement in patient care prior to CABG surgery can significantly contribute to both improving psychosocial adjustment and supporting the recovery process.

Conditions

Interventions

OTHER

Family Involvement-Based Nursing Intervention

The intervention process began with the identification of a family member who could actively participate in the patient's care. These individuals were typically defined as spouses, children, siblings, or close relatives living together. Patients included in the study were admitted to the cardiovascular surgery ward approximately three days before the planned surgery. During this period, routine preoperative preparations were carried out for the patients. These preparations included carotid and saphenous vein Doppler ultrasonography, consultations with the pulmonary medicine and cardiology departments, and preoperative blood preparation

Sponsors & Collaborators

  • Yuzuncu Yil University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-10-30
Primary Completion
2026-04-30
Completion
2026-06-30

Countries

  • Turkey (Türkiye)

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07243925 on ClinicalTrials.gov